BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35253323)

  • 1. Transcriptional suppression of Dicer by HOXB-AS3/EZH2 complex dictates sorafenib resistance and cancer stemness.
    Tseng CF; Chen LT; Wang HD; Liu YH; Shiah SG
    Cancer Sci; 2022 May; 113(5):1601-1612. PubMed ID: 35253323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer of zeste 2 polycomb repressive complex 2 subunit promotes sorafenib resistance of hepatocellular carcinoma though insulin-like growth factor 1 receptor.
    Hu J; Zhang J; Sun F; Qi M; Su P; Liu H; Gao L; Jiao M; Wu Z; Xiang L; Han B
    Anticancer Drugs; 2019 Aug; 30(7):e0746. PubMed ID: 31305292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
    Cai L; Wang Z; Liu D
    Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression.
    Zhang XM; Chen H; Zhou B; Zhang QY; Liao Y; Wang JS; Wang ZH
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6784-6792. PubMed ID: 30402841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting EZH2 as a novel therapeutic strategy for sorafenib-resistant thyroid carcinoma.
    Wang Z; Dai J; Yan J; Zhang Y; Yin Z
    J Cell Mol Med; 2019 Jul; 23(7):4770-4778. PubMed ID: 31087496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib suppresses growth and survival of hepatoma cells by accelerating degradation of enhancer of zeste homolog 2.
    Wang S; Zhu Y; He H; Liu J; Xu L; Zhang H; Liu H; Liu W; Liu Y; Pan D; Chen L; Wu Q; Xu J; Gu J
    Cancer Sci; 2013 Jun; 104(6):750-9. PubMed ID: 23421437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2.
    Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
    Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
    EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells.
    Zhu XX; Yan YW; Chen D; Ai CZ; Lu X; Xu SS; Jiang S; Zhong GS; Chen DB; Jiang YZ
    Oncotarget; 2016 Sep; 7(39):63561-63570. PubMed ID: 27566578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinoma.
    Li Y; Zhuang W; Huang M; Li X
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1051-1057. PubMed ID: 31097223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH; Liu Y; Li JL
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
    BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA HOXB-AS3 binding to PTBP1 protein regulates lipid metabolism by targeting SREBP1 in endometrioid carcinoma.
    Zhou Q; Kong D; Li W; Shi Z; Liu Y; Sun R; Ma X; Qiu C; Liu Z; Hou Y; Jiang J
    Life Sci; 2023 May; 320():121512. PubMed ID: 36858312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin changes in dicer-deficient mouse embryonic stem cells in response to retinoic acid induced differentiation.
    Tennakoon JB; Wang H; Coarfa C; Cooney AJ; Gunaratne PH
    PLoS One; 2013; 8(9):e74556. PubMed ID: 24040281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emodin succinyl ester inhibits malignant proliferation and migration of hepatocellular carcinoma by suppressing the interaction of AR and EZH2.
    Khan H; Jia W; Yu Z; Zaib T; Feng J; Jiang Y; Song H; Bai Y; Yang B; Feng H
    Biomed Pharmacother; 2020 Aug; 128():110244. PubMed ID: 32464306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway.
    Jiang W; Kai J; Li D; Wei Z; Wang Y; Wang W
    J Cell Physiol; 2020 Oct; 235(10):7194-7203. PubMed ID: 32039488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dicer affects cisplatin‑mediated apoptosis in epithelial ovarian cancer cells.
    Wang X; Chen H; Wen Y; Yang X; Han Q; Jiang P; Huang Z; Cai J; Wang Z
    Mol Med Rep; 2018 Nov; 18(5):4381-4387. PubMed ID: 30221734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.